Fresenius Medical Care is up four days in a row, gaining 1.89% and closing at $24.3

A quick look at Friday: after closing Thursday at $23.85, Fresenius Medical Care closed at $24.3 Friday after climbing to $24.45 and dropping back down.

Trend analysis indicates that investors are seeking long positions as Fresenius Medical Care AG & Co. KGaA price action surged above +100 — a key CCI threshold indicating an imminent bullish trend. Analysis based on the asset volatility indicates that Bollinger Band® analysis indicates that current price action is approaching the upper band at $24.68, thereby suggesting that Fresenius Medical Care is becoming overvalued. Technical chart analysis shows Fresenius Medical Care reversed direction at $24.44 resistance zone and retreated back 14 cents below it.

Notwithstanding Fresenius Medical Care's appreciation in recent days, the technical outlook suggests its bullish run is now fading.

Fresenius Medical Care went up Friday, yet these health care stocks did not follow — Astrazeneca PLC went down to $72.12, losing 2.47% after it closed at $73.95 Friday. Pfizer lost 1.11% Friday and closed at $38.3. AbbVie lost 1.08% Friday and closed at $135.92.

The US-German healthcare company has managed to gain 52.3% so far this year despite trading at lows around $12.81 previously.